PREVALENCE AND CLINICAL ASSOCIATIONS OF ANTICARDIOLIPIN ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A PROSPECTIVE-STUDY

被引:18
|
作者
SEBASTIANI, GD [1 ]
PASSIU, G [1 ]
GALEAZZI, M [1 ]
PORZIO, F [1 ]
CARCASSI, U [1 ]
机构
[1] UNIV ROME LA SAPIENZA,CATTEDRA REUMATOL 2,I-00185 ROME,ITALY
关键词
ANTICARDIOLIPIN ANTIBODIES; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; ABORTION; ANTIPHOSPHOLIPID ANTIBODIES;
D O I
10.1007/BF02208692
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The main objectives of the present study were to determine the prevalence of IgG and IgM anticardiolipin antibody (aCL) isotypes in systemic lupus erythematosus (SLE) in order to analyze their possible association with the clinical manifestations of the disease. Clinical features of 64 consecutive and unselected SLE patients were prospectively studied. Sera from the same patients taken during each clinical manifestation were tested for the presence of aCL. The prevalence of aCL was 43.75% for the IgG isotype and 9.4% for the IgM isotype. A strong linkage between the presence of these antibodies and the occurrence of both thrombosis and abortions was found: a weaker association with neurological events and thrombocytopenia was also demonstrated. The titre of aCL appeared to be linked with the probability of having the clinical manifestations associated with these autoantibodies. Our results suggest that thrombosis and abortion, and possibly thrombocytopenia and central nervous system involvement, may be associated with the presence of aCL at the time when these clinical events develop in SLE patients.
引用
收藏
页码:289 / 293
页数:5
相关论文
共 50 条
  • [1] ANTICARDIOLIPIN ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - PREVALENCE AND CLINICAL ASSOCIATIONS
    ABUMOHOR, P
    CERDA, C
    NEIRA, O
    PALMA, S
    ALVARADO, MA
    BASUALDO, J
    BRAVO, M
    GUZMAN, L
    [J]. REVISTA MEDICA DE CHILE, 1991, 119 (05) : 517 - 523
  • [2] PREVALENCE AND CLINICAL ASSOCIATIONS OF ANTICARDIOLIPIN ANTIBODIES IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS IN INDIA
    SALUJA, S
    KUMAR, A
    KHAMASHTA, M
    HUGHES, GRV
    MALAVIYA, AN
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH SECTION B-BIOMEDICAL RESEARCH OTHER THAN INFECTIOUS DISEASES, 1990, 92 : 224 - 227
  • [3] CLINICAL MANIFESTATIONS RELATED WITH ANTICARDIOLIPIN ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - PRELIMINARY-RESULTS OF A PROSPECTIVE-STUDY
    GALEAZZI, M
    SEBASTIANI, GD
    PASSIU, G
    BELLUCCI, AM
    PORZIO, F
    [J]. MEDICINA-RIVISTA DELLA ENCICLOPEDIA MEDICA ITALIANA, 1990, 10 (04): : 403 - 405
  • [4] ANTICARDIOLIPIN ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    SNOWDEN, N
    WILSON, P
    PUMPHREY, R
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1989, 48 (01) : 80 - 82
  • [5] ANTICARDIOLIPIN ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    DANAOCAMARA, T
    CLOUGH, JD
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 1989, 56 (05) : 525 - 528
  • [6] ANTICARDIOLIPIN ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - CLINICAL CORRELATES, HLA ASSOCIATIONS, AND IMPACT ON SURVIVAL
    GULKO, PS
    REVEILLE, JD
    KOOPMAN, WJ
    BURGARD, SL
    BARTOLUCCI, AA
    ALARCON, GS
    [J]. JOURNAL OF RHEUMATOLOGY, 1993, 20 (10) : 1684 - 1693
  • [7] CLINICAL IMPORTANCE OF PERSISTENCE OF ANTICARDIOLIPIN ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    ISHII, Y
    NAGASAWA, K
    MAYUMI, T
    NIHO, Y
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1990, 49 (06) : 387 - 390
  • [8] ANTICARDIOLIPIN ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - CLINICAL AND LABORATORY CORRELATIONS
    ABUSHAKRA, M
    GLADMAN, DD
    UROWITZ, MB
    FAREWELL, V
    [J]. AMERICAN JOURNAL OF MEDICINE, 1995, 99 (06): : 624 - 628
  • [9] CLINICAL-SIGNIFICANCE OF ANTICARDIOLIPIN ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    GANSAUGE, S
    BREITBART, A
    BRADO, B
    BAUM, H
    RINALDI, N
    WERLE, E
    SCHWARZEYWILL, M
    [J]. IMMUNITAT UND INFEKTION, 1995, 23 (01): : 27 - 28
  • [10] LUPUS ANTICOAGULANT AND ANTICARDIOLIPIN ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    SUKENIK, S
    ELROEIY, A
    SHOENFELD, Y
    [J]. ACTA HAEMATOLOGICA, 1986, 76 (2-3) : 86 - 89